PD-1 and PD-L1 — Drug Target
All drugs that target PD-1 and PD-L1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- Full course of PD-1/PD-L1 blockades · Sun Yat-sen University · PD-1/PD-L1 inhibitor · Oncology
PD-1/PD-L1 blockade releases the brakes on the immune system by inhibiting checkpoint proteins that cancer cells use to evade T-cell attack, thereby restoring anti-tumor immunity.